Acadia Pharmaceuticals Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACAD | ATAI | NEU.AX | AXSM | PRAX | B9A.F | |
|---|---|---|---|---|---|---|
| Market cap | 3.70B | — | 2.95B | 7.21B | 7.95B | 2.45B |
| P/E (TTM) | 9.6 | — | 154.9 | — | — | 250.7 |
| Forward P/E | 23.3 | — | 38.9 | 34.0 | -30.0 | — |
| Price/book | 3.0 | — | 8.8 | 68.3 | 5.9 | 1.2 |
| Dividend yield | — | — | 1.52% | — | — | 0.68% |
| 1-year change | −7.88% | — | −2.22% | +2.89% | +70.38% | +5.23% |
| Today | +4.38% | 0.00% | +17.49% | −1.87% | +1.53% | −0.29% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All ACAD news ›Acadia Pharmaceuticals Announces Phase 3 Enabling Topline Results from Phase 2 RADIANT Study of Remlifanserin for the Treatment of Alzheimer’s Disease Psychosis (ADP)
-- Meaningful and consistent efficacy trends across endpoints support continuing with Phase 3 development of 60 mg once daily remlifanserin in ADP, with demonstrated evidence of dose effect -- Narrowly missed primary endpoint of SAPS H+D…
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ACADIA Pharmaceuticals Inc. - ACAD
/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ACADIA Pharmaceuticals Inc. ("Acadia" or the "Company") (NASDAQ: ACAD). Such... NEW YORK, Oct. 29, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims…
ACG Acquisition’s (ACG) Buy Rating Reiterated at Berenberg Bank
Posted by Mitch Edgeman on Nov 3rd, 2026 ACG Acquisition (LON:ACG – Get Free Report)‘s stock had its “buy” rating reiterated by analysts at Berenberg Bank in a research note issued on Tuesday, Digital Look reports. They presently have a…
Wall Street Zen Upgrades AbCellera Biologics (NASDAQ:ABCL) to Hold
Posted by Tristan Rich on Oct 31st, 2026 AbCellera Biologics (NASDAQ:ABCL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “sell” rating to a “hold” rating in a research report issued to clients and…
Acadia Pharmaceuticals and Stoke Therapeutics Announce Collaboration to Pursue Multiple RNA-based Treatments for Severe and Rare Genetic Neurodevelopmental Diseases
– Establishes co-development and co-commercialization agreement for Stoke’s SYNGAP1 preclinical program – Acadia receives exclusive worldwide licenses for two additional preclinical programs: Rett syndrome (MECP2) and undisclosed…
ACADIA Pharmaceuticals (ACAD) – Analysts’ Weekly Ratings Changes
Several brokerages have updated their recommendations and price targets on shares of ACADIA Pharmaceuticals (NASDAQ: ACAD) in the last few weeks: 10/19/2026 – ACADIA Pharmaceuticals had its “buy” rating reaffirmed by Needham & Company LLC.…
Aclaris Therapeutics, Inc. (ACRS) – What Are Analysts Saying About This Stock?
Shares of Aclaris Therapeutics, Inc. (NASDAQ:ACRS – Get Free Report) have earned an average recommendation of “Buy” from the nine brokerages that are covering the firm, Marketbeat Ratings reports. One investment analyst has rated the stock…
Afentra (LON:AET) Stock Keeps Buy Rating at Canaccord Genuity Group
Afentra (LON:AET – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at Canaccord Genuity Group in a report released on Wednesday, Digital Look reports. They currently have a GBX 135 price target on the stock.…
Citi Remains a Buy on Acumen Pharmaceuticals (ABOS)
Citi analyst Geoff Meacham maintained a Buy rating on Acumen Pharmaceuticals today and set a price target of $5.00. According to TipRanks, Meacham is a 5-star analyst with an average return of 12.7% and a 56.16% success rate. Meacham…
Abivax (NASDAQ:ABVX) Stock Rating Reaffirmed as "Buy" by Guggenheim
Abivax (NASDAQ:ABVX - Get Free Report)'s stock had its "buy" rating reissued by stock analysts at Guggenheim in a report issued on Tuesday, Benzinga reports. They presently have a $175.00 price target on the stock. Guggenheim's price…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- defenseworld.net9
- marketscreener.com6
- themarketsdaily.com5
- markets.businessinsider.com3
- accessnewswire.com2
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 32 articles, not a forecast.